$4950 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD
[POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025
[Lowest Price Guaranteed: $4,950]

Published by MarketsandMarkets: 15 May 2020 | 261002 | In Stock
Related Topics: Abbott , Roche

Introduction

“The microfluidics market is projected to grow at a CAGR of 22.9%.”

The global microfluidics market size is projected to reach USD 44.0 billion by 2025 from USD 15.7 billion in 2020, at a CAGR of 22.9% during the forecast period. The ability of the microfluidics technology to replicate all the functions of its traditional counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) diagnostics, and clinical diagnostics, is resulting in its wider adoption across the globe. In addition to this, technological advancements, increasing focus on data precision & accuracy, fast returns on investment, and faster testing & improved portability through microfluidic chip miniaturization are driving growth of the microfluidics industry.

“In 2019, in-vitro diagnostics accounted for the largest share of the market.”

Based on the application, the in-vitro diagnostics segment accounted for the largest share of the microfluidics market in 2019. The large share of this segment can be attributed to the increasing integration of microfluidics with laboratory analytical instruments, growing need for portable diagnostic equipment, and increasing demand for point-of-care testing.

“In 2019, the hospitals & diagnostic centers segment accounted for the largest share of the market.”

Based on end-users, the hospitals & diagnostic centers segment accounted for the largest share of the microfluidics market in 2019. The large share of this segment is attributed to the increasing use of microfluidic-based diagnostic devices, increasing adoption of microfluidics for the rapid diagnosis of various chronic diseases, technological advancements, and the inherent advantages of microfluidics

“APAC is projected to witness the highest growth during the forecast period.”

The APAC microfluidics market is estimated to register the highest CAGR during the forecast period. Factors such as the growing geriatric population, growing per capita income, increasing investments in the healthcare industry, rising demand for advanced technologies, and the expansion of private-sector hospitals to rural areas in various countries in the region.

The breakdown of primary participants was as mentioned below:

• By Company Type: Tier 1–53%, Tier 2–26%, and Tier 3–21%

• By Designation: C-level–42%, Director Level–26%, and Others–32%

• By Region: North America–26%, Europe–35%, Asia Pacific–20%, Latin America–11%, Middle East & Africa–8%

The global microfluidics market is highly competitive, with a large number of global and local market players competing for higher market shares. Danaher Corporation (US), Thermo Fisher Scientific (US), PerkinElmer Inc. (US), Agilent Technologies (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), F. Hoffmann-La Roche (Switzerland), Illumina, Inc. (US), Fluidigm Microfluidics (US), Abbott Laboratories (US), and QIAGEN (Netherlands) are some of the prominent players in the microfluidic-based devices market.

The prominent players in the global microfluidic components market include Parker-Hannifin Corporation (US), Fluigent SA (France), Idex Corporation (US), Camozzi Automation Spa Società Unipersonale (Italy), Gems Sensors and Control (US), Aignep S.P.A. (Italy), SMC Corporation (Japan), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), Microfluidic ChipShop (Germany), Micronit Microtechnologies (Netherlands), and MicroLiquid (Spain).

Research Coverage:

The report analyzes the various infusion pump devices and their adoption patterns. It aims at estimating the market size and future growth potential of the microfluidics market for different segments such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microfluidics industry

• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the microfluidics market

• Market Development: Comprehensive information on the lucrative emerging regions by product, application, end user, and region

• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microfluidics industry

• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the microfluidics market

Table of Contents
for Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025

  • TABLE OF CONTENTS

    1 INTRODUCTION 24

    1.1 OBJECTIVES OF THE STUDY 24

    1.2 MARKET DEFINITION AND SCOPE 25

    1.2.1 MARKETS COVERED 26

    1.2.2 YEARS CONSIDERED FOR THE STUDY 27

    1.3 CURRENCY 27

    1.4 LIMITATIONS 27

    1.5 STAKEHOLDERS 28

    2 RESEARCH METHODOLOGY 29

    2.1 RESEARCH APPROACH 29

    2.1.1 SECONDARY DATA 30

    2.1.1.1 Key data from secondary sources 31

    2.1.2 PRIMARY DATA 31

    2.1.2.1 Key data from primary sources 33

    2.1.2.2 Key industry insights 34

    2.2 MARKET SIZE ESTIMATION 35

    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41

    2.4 ASSUMPTIONS FOR THE STUDY 42

    3 EXECUTIVE SUMMARY 43

    4 PREMIUM INSIGHTS 48

    4.1 GROWTH POTENTIAL OF THE MICROFLUIDICS MARKET 48

    4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER 49

    4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50

    4.4 MICROFLUIDICS MARKET, BY REGION 50

    4.5 MICROFLUIDICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 51

    5 MARKET OVERVIEW 52

    5.1 INTRODUCTION 52

    5.2 MARKET DYNAMICS 52

    5.2.1 DRIVERS 53

    5.2.1.1 Rising demand for point-of-care testing 53

    5.2.1.2 Technological advancements 54

    5.2.1.3 Increasing focus on data precision and accuracy 54

    5.2.1.4 Fast returns on investment 54

    5.2.1.5 Faster testing and improved portability through microfluidic

    chip miniaturization 55

    5.2.1.6 Entry of new players and launch of new and advanced products 55

    5.2.2 RESTRAINTS 57

    5.2.2.1 Complex and time-consuming regulatory approval process 57

    5.2.2.2 Incorporation of microfluidics into existing workflows 57

    5.2.3 OPPORTUNITIES 58

    5.2.3.1 Emergence of microfluidic-based 3D cell culture systems,

    such as organ-on-a-chip 58

    5.2.3.2 Asia—a key growth hotspot 59

    5.2.3.3 Expanding applications of drug delivery technologies 59

    5.2.3.4 Growing applications of microfluidics 60

    5.2.4 CHALLENGES 60

    5.2.4.1 Standardization/commercialization of microfluidic devices 60

    6 INDUSTRY INSIGHTS 61

    6.1 INTRODUCTION 61

    6.2 INDUSTRY TRENDS 61

    6.2.1 SHIFTING TREND TOWARDS EHEALTH DIAGNOSTICS WITH THE INTEGRATION OF MICROFLUIDICS-BASED POC DEVICES, EPIDERMAL ELECTRONICS,

    AND IOT 62

    6.2.2 ADOPTION OF 3D PRINTING IN MICROFLUIDICS 62

    6.2.3 SHIFTING TREND TOWARDS THE ADOPTION OF POLYMERS 63

    6.2.4 UNIVERSITIES ACTIVELY INVESTING IN MICROFLUIDIC START-UPS AND LARGE PLAYERS ACQUIRING SMALL PLAYERS 63

    6.3 ANALYSIS OF PARENT MARKETS 65

    6.4 EVOLUTION OF MICROFLUIDICS IN HEALTHCARE 71

    6.5 VALUE CHAIN ANALYSIS 71

    6.5.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS 73

    7 MICROFLUIDICS MARKET, BY PRODUCT 74

    7.1 INTRODUCTION 75

    7.2 MICROFLUIDIC-BASED DEVICES 75

    7.2.1 INCREASING ADOPTION OF MICROFLUIDIC DEVICES OWING TO THE VARIOUS ADVANTAGES OFFERED BY THEM TO DRIVE MARKET GROWTH 75

    7.3 MICROFLUIDIC COMPONENTS 76

    7.3.1 MICROFLUIDIC CHIPS 78

    7.3.1.1 Microfluidic chips reduce the analysis time by increasing automation and consume low volumes of samples 78

    7.3.2 FLOW AND PRESSURE SENSORS 82

    7.3.2.1 These devices offer a range of advantages, due to which they are increasingly used in laboratories and research institutes 82

    7.3.3 FLOW AND PRESSURE CONTROLLERS 84

    7.3.3.1 Due to high accuracy and control stability, pressure controllers are suitable as references for laboratories 84

    7.3.4 MICROPUMPS 86

    7.3.4.1 Need for precision in fluid control and device miniaturization has favored the growth of the micropumps market 86

    7.3.5 MICROFLUIDIC VALVES 88

    7.3.5.1 Valves are a vital component in microfluidic devices—a key factor driving market growth 88

    7.3.6 MICRONEEDLES 92

    7.3.6.1 Small size of microneedles leaves dermal nerves and blood vessels unaffected, ensuring a painless procedure 92

    7.3.7 OTHER COMPONENTS 94

    8 MICROFLUIDICS MARKET, BY APPLICATION 96

    8.1 INTRODUCTION 97

    8.2 IN VITRO DIAGNOSTICS 97

    8.2.1 POINT-OF-CARE TESTING 99

    8.2.1.1 Point-of-care testing is the largest application segment in the microfluidics market for in vitro diagnostics 99

    8.2.2 CLINICAL DIAGNOSTICS 100

    8.2.2.1 Increase in viral outbreaks to drive growth in the clinical diagnostics segment 100

    8.2.3 VETERINARY DIAGNOSTICS 101

    8.2.3.1 Growing need for low-cost, rapid, and reliable diagnostic results in veterinary medicine to drive market growth 101

    8.3 PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING 102

    8.3.1 LAB ANALYTICS 104

    8.3.1.1 Proteomic analysis 106

    8.3.1.1.1 Increasing demand for rapid proteomic analysis for drug development is fueling the demand for lab-on-a-chip devices 106

    8.3.1.2 Genomic analysis 107

    8.3.1.2.1 Increasing focus on the decoding of genomes to boost the adoption of microfluidics in genomics 107

    8.3.1.3 Cell-based assays 109

    8.3.1.3.1 Increasing focus on microfluidic cell-based assays for rapid drug development aids market growth 109

    8.3.1.4 Capillary electrophoresis 110

    8.3.1.4.1 Combination of microfluidic capillary electrophoresis with other technologies to drive overall market growth 110

    8.3.2 MICRODISPENSING 111

    8.3.2.1 Advantages such as less sample and reagent consumption and ease of operation drive the adoption of microdispensing systems 111

    8.3.3 MICROREACTION 112

    8.3.3.1 Increasing need for optimization in the research and production process using microfluidic techniques drives the market growth 112

    8.4 THERAPEUTICS 114

    8.4.1 DRUG DELIVERY 115

    8.4.1.1 Expanding applications of microfluidics in the development of drug delivery platforms are a key driver for market growth 115

    8.4.2 WEARABLE DEVICES 116

    8.4.2.1 Increasing demand for microfluidics-integrated wearable devices for patient vital sign monitoring drives overall growth 116

    9 MICROFLUIDICS MARKET, BY END USER 118

    9.1 INTRODUCTION 119

    9.2 HOSPITALS AND DIAGNOSTIC CENTERS 119

    9.2.1 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE LARGEST END USERS OF MICROFLUIDICS 119

    9.3 ACADEMIC AND RESEARCH INSTITUTES 121

    9.3.1 USE OF MICROFLUIDICS IN RESEARCH IS EXPECTED TO INCREASE WITH GROWING FUNDING IN THE FIELD 121

    9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 123

    9.4.1 INCREASING FOCUS ON LAUNCHING QUALITY DRUGS TO SUPPORT MARKET GROWTH 123

    10 MICROFLUIDICS MARKET, BY REGION 126

    10.1 INTRODUCTION 127

    10.2 NORTH AMERICA 128

    10.2.1 US 133

    10.2.1.1 The US dominates the North American microfluidics market 133

    10.2.2 CANADA 137

    10.2.2.1 Strong infrastructure and availability of funding for biomedical research will support market growth 137

    10.3 EUROPE 140

    10.3.1 GERMANY 144

    10.3.1.1 Germany holds the largest share in the European market 144

    10.3.2 FRANCE 148

    10.3.2.1 Genomics and proteomics research is strongly supported by the government of France 148

    10.3.3 UK 152

    10.3.3.1 Increasing incidence of infectious diseases such as COVID-19 drives the growth of PoC testing and microfluidics 152

    10.3.4 ITALY 155

    10.3.4.1 Increasing demand for PoC testing aids market growth 155

    10.3.5 SPAIN 159

    10.3.5.1 Increasing incidence of infectious and chronic diseases drives

    the growth of the market 159

    10.3.6 REST OF EUROPE 162

    10.4 ASIA PACIFIC 166

    10.4.1 CHINA 171

    10.4.1.1 China holds a major share in the Asia Pacific microfluidics market 171

    10.4.2 JAPAN 175

    10.4.2.1 Adoption of technologically advanced laboratory analytical instruments in research to drive market growth in Japan 175

    10.4.3 INDIA 179

    10.4.3.1 Increasing pharma R&D and government funding in the biotechnology sector is a major source of market growth 179

    10.4.4 REST OF ASIA PACIFIC 183

    10.5 LATIN AMERICA 187

    10.5.1 BRAZIL 190

    10.5.1.1 Pharmaceutical & biologics QC to drive market growth in Brazil 190

    10.5.2 MEXICO 193

    10.5.2.1 Rising prevalence of chronic diseases drives the growth of

    the microfluidics market in Mexico 193

    10.5.3 REST OF LATIN AMERICA 196

    10.6 MIDDLE EAST & AFRICA 199

    10.6.1 THE MEA IS CONSIDERED A PROMISING REGION, ESPECIALLY FOR MICROFLUIDIC DRUG DELIVERY FIRMS 199

    11 COMPETITIVE LANDSCAPE 203

    11.1 OVERVIEW 203

    11.2 PRODUCT PORTFOLIO MATRIX 204

    11.3 COMPETITIVE SITUATION AND TRENDS 205

    11.3.1 PRODUCT LAUNCHES 206

    11.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 207

    11.3.3 ACQUISITIONS 208

    11.3.4 EXPANSIONS 209

    11.4 COMPETITIVE LEADERSHIP MAPPING 212

    11.4.1 VISIONARY LEADERS 212

    11.4.2 INNOVATORS 212

    11.4.3 DYNAMIC DIFFERENTIATORS 212

    11.4.4 EMERGING COMPANIES 213

    12 COMPANY PROFILES 214

    (Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview, Competitive Analysis)*

    12.1 PARKER-HANNIFIN CORPORATION 214

    12.2 SMC CORPORATION 219

    12.3 IDEX CORPORATION 224

    12.4 FLUIGENT SA 228

    12.5 DOLOMITE MICROFLUIDICS 231

    12.6 AIGNEP S.P.A. 236

    12.7 CAMOZZI AUTOMATION SPA SOCIETÀ UNIPERSONALE 237

    12.8 ELVEFLOW 238

    12.9 CELLIX LTD. 240

    12.10 FORTIVE CORPORATION 241

    12.11 DANAHER CORPORATION 245

    12.12 THERMO FISHER SCIENTIFIC INC. 249

    12.13 PERKINELMER, INC. 253

    12.14 AGILENT TECHNOLOGIES, INC. 257

    12.15 BIO-RAD LABORATORIES, INC. 261

    12.16 BECTON, DICKINSON AND COMPANY 265

    12.17 ILLUMINA, INC. 267

    12.18 F. HOFFMANN-LA ROCHE LTD. 270

    12.19 FLUIDIGM CORPORATION 272

    12.20 ABBOTT LABORATORIES 275

    *Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview, Competitive Analysis might not be captured in case of unlisted companies.

    13 APPENDIX 277

    13.1 INSIGHTS FROM INDUSTRY EXPERTS 277

    13.2 DISCUSSION GUIDE 278

    13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 283

    13.4 AVAILABLE CUSTOMIZATIONS 285

    13.5 RELATED REPORTS 285

    13.6 AUTHOR DETAILS 286

List Of Tables
in Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025

LIST OF TABLES


TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 27

TABLE 2 SOME OF THE NEW PRODUCTS LAUNCHED BY MAJOR PLAYERS IN

THE LAST THREE YEARS HAVE BEEN MENTIONED BELOW: 56

TABLE 3 IMPACT ANALYSIS: MARKET DRIVERS 57

TABLE 4 IMPACT ANALYSIS: MARKET RESTRAINTS 58

TABLE 5 IMPACT ANALYSIS: MARKET OPPORTUNITIES 60

TABLE 6 IMPACT ANALYSIS: MARKET CHALLENGES 60

TABLE 7 LIST OF UNIVERSITY STARTUPS IN THE MICROFLUIDICS MARKET 63

TABLE 8 MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 75

TABLE 9 MICROFLUIDIC-BASED DEVICES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 76

TABLE 10 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 77

TABLE 11 MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 78

TABLE 12 MICROFLUIDIC CHIPS AVAILABLE IN THE MARKET 79

TABLE 13 MICROFLUIDIC CHIPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 82

TABLE 14 FLOW AND PRESSURE SENSORS AVAILABLE IN THE MARKET 83

TABLE 15 FLOW AND PRESSURE SENSORS MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 84

TABLE 16 FLOW AND PRESSURE CONTROLLERS AVAILABLE IN THE MARKET 85

TABLE 17 FLOW AND PRESSURE CONTROLLERS MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 86

TABLE 18 MICROPUMPS AVAILABLE IN THE MARKET 87

TABLE 19 MICROPUMPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 88

TABLE 20 MICROFLUIDIC VALVES AVAILABLE IN THE MARKET 89

TABLE 21 MICROFLUIDIC VALVES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 92

TABLE 22 MICRONEEDLES AVAILABLE IN THE MARKET 93

TABLE 23 MICRONEEDLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 94

TABLE 24 OTHER MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 95

TABLE 25 MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 97

TABLE 26 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 98

TABLE 27 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,

2018–2025 (USD MILLION) 98

TABLE 28 MICROFLUIDICS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY,

2018–2025 (USD MILLION) 100

TABLE 29 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY,

2018–2025 (USD MILLION) 101

TABLE 30 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY,

2018–2025 (USD MILLION) 102

TABLE 31 MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 103

TABLE 32 MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY COUNTRY, 2018–2025 (USD MILLION) 104

TABLE 33 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 105

TABLE 34 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY COUNTRY,

2018–2025 (USD MILLION) 106

TABLE 35 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY COUNTRY,

2018–2025 (USD MILLION) 107

TABLE 36 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY COUNTRY,

2018–2025 (USD MILLION) 108

TABLE 37 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY,

2018–2025 (USD MILLION) 109

TABLE 38 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2018–2025 (USD MILLION) 111

TABLE 39 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY COUNTRY,

2018–2025 (USD MILLION) 112

TABLE 40 MICROFLUIDICS MARKET FOR MICROREACTION, BY COUNTRY,

2018–2025 (USD MILLION) 113

TABLE 41 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE,

2018–2025 (USD MILLION) 114

TABLE 42 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY,

2018–2025 (USD MILLION) 115

TABLE 43 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY COUNTRY,

2018–2025 (USD MILLION) 116

TABLE 44 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY COUNTRY,

2018–2025 (USD MILLION) 117

TABLE 45 MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 119

TABLE 46 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS,

BY COUNTRY, 2018–2025 (USD MILLION) 120

TABLE 47 MICROFLUIDICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,

BY COUNTRY, 2018–2025 (USD MILLION) 123

TABLE 48 MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 125

TABLE 49 MICROFLUIDICS MARKET, BY REGION, 2018–2025 (USD MILLION) 128

TABLE 50 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 130

TABLE 51 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 130

TABLE 52 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 131

TABLE 53 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION,

2018–2025 (USD MILLION) 131

TABLE 54 NORTH AMERICA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018–2025 (USD MILLION) 132

TABLE 55 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 132

TABLE 56 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 132

TABLE 57 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,

BY TYPE, 2018–2025 (USD MILLION) 133

TABLE 58 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER,

2018–2025 (USD MILLION) 133

TABLE 59 US: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 134

TABLE 60 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 134

TABLE 61 US: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 135

TABLE 62 US: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 135

TABLE 63 US: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 135

TABLE 64 US: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 136

TABLE 65 US: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE,

2018–2025 (USD MILLION) 136

TABLE 66 US: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 136

TABLE 67 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 138

TABLE 68 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 138

TABLE 69 CANADA: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 138

TABLE 70 CANADA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 139

TABLE 71 CANADA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 139

TABLE 72 CANADA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 139

TABLE 73 CANADA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 140

TABLE 74 CANADA: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 140

TABLE 75 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 141

TABLE 76 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 142

TABLE 77 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 142

TABLE 78 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 142

TABLE 79 EUROPE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 143

TABLE 80 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 143

TABLE 81 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 143

TABLE 82 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 144

TABLE 83 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 144

TABLE 84 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 145

TABLE 85 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 146

TABLE 86 GERMANY: MICROFLUIDICS MARKET, BY APPLICATION,

2018–2025 (USD MILLION) 146

TABLE 87 GERMANY: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 147

TABLE 88 GERMANY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 147

TABLE 89 GERMANY: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 147

TABLE 90 GERMANY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 148

TABLE 91 GERMANY: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 148

TABLE 92 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 149

TABLE 93 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 149

TABLE 94 FRANCE: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 150

TABLE 95 FRANCE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 150

TABLE 96 FRANCE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 150

TABLE 97 FRANCE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 151

TABLE 98 FRANCE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 151

TABLE 99 FRANCE: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 151

TABLE 100 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 152

TABLE 101 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 153

TABLE 102 UK: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 153

TABLE 103 UK: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 154

TABLE 104 UK: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 154

TABLE 105 UK: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 154

TABLE 106 UK: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE,

2018–2025 (USD MILLION) 155

TABLE 107 UK: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 155

TABLE 108 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 156

TABLE 109 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 156

TABLE 110 ITALY: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 157

TABLE 111 ITALY: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 157

TABLE 112 ITALY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 157

TABLE 113 ITALY: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 158

TABLE 114 ITALY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 158

TABLE 115 ITALY: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 158

TABLE 116 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 159

TABLE 117 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 160

TABLE 118 SPAIN: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 160

TABLE 119 SPAIN: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 161

TABLE 120 SPAIN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 161

TABLE 121 SPAIN: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 161

TABLE 122 SPAIN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 162

TABLE 123 SPAIN: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 162

TABLE 124 ROE: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 163

TABLE 125 ROE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 163

TABLE 126 ROE: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 164

TABLE 127 ROE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 164

TABLE 128 ROE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 164

TABLE 129 ROE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 165

TABLE 130 ROE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE,

2018–2025 (USD MILLION) 165

TABLE 131 ROE: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 165

TABLE 132 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 168

TABLE 133 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 168

TABLE 134 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 169

TABLE 135 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION,

2018–2025 (USD MILLION) 169

TABLE 136 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018–2025 (USD MILLION) 170

TABLE 137 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 170

TABLE 138 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 170

TABLE 139 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,

BY TYPE, 2018–2025 (USD MILLION) 171

TABLE 140 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER,

2018–2025 (USD MILLION) 171

TABLE 141 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 172

TABLE 142 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 173

TABLE 143 CHINA: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 173

TABLE 144 CHINA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 174

TABLE 145 CHINA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 174

TABLE 146 CHINA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 174

TABLE 147 CHINA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 175

TABLE 148 CHINA: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 175

TABLE 149 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 177

TABLE 150 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 177

TABLE 151 JAPAN: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 177

TABLE 152 JAPAN: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 178

TABLE 153 JAPAN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 178

TABLE 154 JAPAN: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 178

TABLE 155 JAPAN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 179

TABLE 156 JAPAN: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 179

TABLE 157 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 180

TABLE 158 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 181

TABLE 159 INDIA: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 181

TABLE 160 INDIA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 182

TABLE 161 INDIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 182

TABLE 162 INDIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 182

TABLE 163 INDIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 183

TABLE 164 INDIA: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 183

TABLE 165 ROAPAC: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 184

TABLE 166 ROAPAC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 184

TABLE 167 ROAPAC: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 185

TABLE 168 ROAPAC: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 185

TABLE 169 ROAPAC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 185

TABLE 170 ROAPAC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 186

TABLE 171 ROAPAC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 186

TABLE 172 ROAPAC: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 186

TABLE 173 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 187

TABLE 174 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 187

TABLE 175 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 188

TABLE 176 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION,

2018–2025 (USD MILLION) 188

TABLE 177 LATIN AMERICA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018–2025 (USD MILLION) 189

TABLE 178 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 189

TABLE 179 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 189

TABLE 180 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,

BY TYPE, 2018–2025 (USD MILLION) 190

TABLE 181 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER,

2018–2025 (USD MILLION) 190

TABLE 182 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 191

TABLE 183 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 191

TABLE 184 BRAZIL: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 191

TABLE 185 BRAZIL: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 192

TABLE 186 BRAZIL: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 192

TABLE 187 BRAZIL: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 192

TABLE 188 BRAZIL: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 193

TABLE 189 BRAZIL: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 193

TABLE 190 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 194

TABLE 191 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 194

TABLE 192 MEXICO: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 194

TABLE 193 MEXICO: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 195

TABLE 194 MEXICO: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 195

TABLE 195 MEXICO: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 195

TABLE 196 MEXICO: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 196

TABLE 197 MEXICO: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 196

TABLE 198 ROLA: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 196

TABLE 199 ROLA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 197

TABLE 200 ROLA: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 197

TABLE 201 ROLA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 198

TABLE 202 ROLA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 198

TABLE 203 ROLA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 198

TABLE 204 ROLA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 199

TABLE 205 ROLA: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 199

TABLE 206 MEA: MICROFLUIDICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 200

TABLE 207 MEA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,

2018–2025 (USD MILLION) 200

TABLE 208 MEA: MICROFLUIDICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 201

TABLE 209 MEA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2018–2025 (USD MILLION) 201

TABLE 210 MEA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018–2025 (USD MILLION) 201

TABLE 211 MEA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,

2018–2025 (USD MILLION) 202

TABLE 212 MEA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE,

2018–2025 (USD MILLION) 202

TABLE 213 MEA: MICROFLUIDICS MARKET, BY END USER, 2018–2025 (USD MILLION) 202

TABLE 214 PRODUCT PORTFOLIO ANALYSIS OF MAJOR PLAYERS IN THE MARKET 204

TABLE 215 PRODUCT LAUNCHES & APPROVALS 206

TABLE 216 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 207

TABLE 217 ACQUISITIONS 208

TABLE 218 EXPANSIONS 209

List Of Figures, Charts and Diagrams
in Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025

LIST OF FIGURES


FIGURE 1 RESEARCH DESIGN 29

FIGURE 2 PRIMARY SOURCES 32

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE) 34

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE) 35

FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36

FIGURE 6 REVENUE SHARE ANALYSIS 36

FIGURE 7 SUPPLY-SIDE ANALYSIS OF THE MICROFLUIDICS MARKET 37

FIGURE 8 MICROFLUIDICS MARKET: CAGR PROJECTIONS FROM THE SUPPLY SIDE 39

FIGURE 9 TOP-DOWN APPROACH 40

FIGURE 10 DATA TRIANGULATION METHODOLOGY 41

FIGURE 11 MICROFLUIDICS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 43

FIGURE 12 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 44

FIGURE 13 MICROFLUIDICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 45

FIGURE 14 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,

2020 VS. 2025 (USD MILLION) 45

FIGURE 15 MICROFLUIDICS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 46

FIGURE 16 GEOGRAPHIC ANALYSIS: GLOBAL MICROFLUIDICS MARKET 47

FIGURE 17 RISING DEMAND FOR POINT-OF-CARE TESTING IS DRIVING THE GROWTH OF

THE GLOBAL MICROFLUIDICS MARKET 48

FIGURE 18 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MICROFLUIDICS MARKET IN 2019 49

FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH RATE IN THE MICROFLUIDICS MARKET DURING THE FORECAST PERIOD 50

FIGURE 20 NORTH AMERICA TO DOMINATE THE GLOBAL MICROFLUIDICS MARKET DURING THE FORECAST PERIOD 50

FIGURE 21 HIGH GROWTH OPPORTUNITIES IN BOTH DEVELOPING AND DEVELOPED MARKETS DURING THE FORECAST PERIOD 51

FIGURE 22 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES 52

FIGURE 23 GLOBAL CANCER INCIDENCE, 2015–2040 53

FIGURE 24 SHIFT TOWARDS EHEALTH DIAGNOSTICS WITH THE INTEGRATION OF MICROFLUIDIC-BASED POC DEVICES, EPIDERMAL ELECTRONICS, AND IOT 61

FIGURE 25 PROTEOMICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING

THE FORECAST PERIOD 65

FIGURE 26 IN VITRO DIAGNOSTICS MARKET SNAPSHOT 66

FIGURE 27 POINT-OF-CARE DIAGNOSTICS MARKET SNAPSHOT 67

FIGURE 28 PROTEOMICS MARKET SNAPSHOT 68

FIGURE 29 GENOMICS MARKET SNAPSHOT 69

FIGURE 30 CAPILLARY ELECTROPHORESIS SYSTEMS MARKET SNAPSHOT 70

FIGURE 31 VALUE CHAIN ANALYSIS 73

FIGURE 32 LAB ANALYTICS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING IN 2019 103

FIGURE 33 PROTEOMIC ANALYSIS TO DOMINATE THE LAB ANALYTICS MARKET DURING

THE FORECAST PERIOD 105

FIGURE 34 DRUG DELIVERY APPLICATIONS TO DOMINATE THE THERAPEUTICS MARKET DURING THE FORECAST PERIOD 114

FIGURE 35 LIFE SCIENCE R&D SPENDING, 2017–2019 122

FIGURE 36 FDA APPROVALS FOR PERSONALIZED MEDICINES (2014–2018) 124

FIGURE 37 MICROFLUIDICS MARKET: GEOGRAPHIC SNAPSHOT (2019) 127

FIGURE 38 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT 129

FIGURE 39 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT 167

FIGURE 40 KEY DEVELOPMENTS IN THE MICROFLUIDICS MARKET (2018–2020) 203

FIGURE 41 COMPARATIVE ASSESSMENT OF KEY PLAYERS FOR R&D EXPENDITURE

(2017 VS. 2019) 210

FIGURE 42 COMPETITIVE ASSESSMENT OF KEY PLAYERS IN THE MICROFLUIDICS MARKET,

BY REGION (2019) 211

FIGURE 43 MICROFLUIDICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 213

FIGURE 44 PARKER-HANNIFIN CORPORATION: COMPANY SNAPSHOT (2019) 214

FIGURE 45 SMC CORPORATION: COMPANY SNAPSHOT (2019) 219

FIGURE 46 IDEX CORPORATION :COMPANY SNAPSHOT (2019) 224

FIGURE 47 FORTIVE CORPORATION: COMPANY SNAPSHOT (2019) 242

FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 245

FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019) 249

FIGURE 50 PERKINELMER, INC.: COMPANY SNAPSHOT (2019) 253

FIGURE 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019) 257

FIGURE 52 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 261

FIGURE 53 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 265

FIGURE 54 ILLUMINA, INC.: COMPANY SNAPSHOT (2019) 267

FIGURE 55 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019) 270

FIGURE 56 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2018) 272

FIGURE 57 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 275

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

261002 | AST 7541

Number of Pages

287

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Microfluidics Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Microfluidics Mar...
23 Oct 2017 by S&P Consulting USD $2,800 More Info
Biochips (Microarrays/Microfluidics) Global Market – Forecast To 2023
Biochips come handy as thousands of experiments are performed on a small chip with a solid platform ...
22 Jun 2017 by IQ4I USD $4,950 More Info
Biochips (Microarrays/Microfluidics) Global Market – Forecast To 2023
Biochips come handy as thousands of experiments are performed on a small chip with a solid platform ...
22 Jun 2017 by IQ4I USD $4,950 More Info
Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026
With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics...
06 Feb 2017 by Future Market Insights USD $5,000 More Info
Std Reimbursement Scenario Analysis And Top Std Testing Technologies (Pcr, Immunochromatographic Capillary Flow Dipstick Technology, Flow Cytometry, Differential Light Scattering, Enzyme Linked Immunosorbent Assay, Rapid Diagnostic Kits, Phone Chips, Microfluidics, And Immunochromatographic Tests) - Global Opportunity Analysis And Industry Forecast, 2014 - 2022
The market revenue for diagnostic testing of STDs was valued at 7,024 million in 2015, and is pro...
13 Dec 2016 by Allied Market Research USD $2,500 More Info
Microfluidics Market by Component (Microfluidic Chips, Micropump, Microneedle), Material (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, Drug Delivery) - Global Forecast to 2021
Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to ...
06 Dec 2016 by MarketsandMarkets USD $5,650 More Info
Std Reimbursement Scenario Analysis And Top Std Testing Technologies (Pcr, Immunochromatographic Capillary Flow Dipstick Technology, Flow Cytometry, Differential Light Scattering, Enzyme Linked Immunosorbent Assay, Rapid Diagnostic Kits, Phone Chips, Microfluidics, And Immunochromatographic Tests) - Global Opportunity Analysis And Industry Forecast, 2014 - 2022
The market revenue for diagnostic testing of STDs was valued at 7,024 million in 2015, and is pro...
01 Dec 2016 by Allied Market Research USD $2,500 More Info
Organ-on-Chip Global Market 2010-2020 Including: Lung-on-chip, Heart-on-chip, Liver-on-chip, Intestine-on-chip, Kidney-on-chip and Human-on-chip, Human disease and tissue models, Microfluidics Historic and Forecast 2010 – 2020 Covering: North America, Europe, Rest Of World (ROW)
Organ-on-chips or organ-on-a-chips (OOCs) are microfluidic 3D cell culture devices that closely mimi...
30 May 2016 by The Business Research Company USD $4,000 More Info
Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020
Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to ...
22 Jun 2015 by MarketsandMarkets USD $5,650 More Info
Global Microfluidics Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Microfluidics Mar...
01 Jan 1970 by S&P Consulting USD $2,800 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...